NewsJames Fisher's Middle-East impairmentThe marine engineer has taken a hit from a failed investment in Saudi ArabiaSave27 February 2020
NewsNichols scrambles to offset excise hikeThe Merseyside pop group is having further issues with the taxmanSave26 February 2020
¹û¶³´«Ã½ of the WeekClinigen's progress comes at a priceThe pharma group's US prospects have improved, though this has come at a priceSave25 February 2020
NewsDechra's non-pandemic supply issuesThe veterinary pharma group has been struggling with supply chain issues - the shape of things to come?Save24 February 2020
¹û¶³´«Ã½ of the WeekSmith & Nephew's emerging priorities The medical technology group continues to prioritise R&D spendingSave20 February 2020
¹û¶³´«Ã½ of the WeekPan African anticipates lower 2H costsThe SA gold miner is looking towards lower-cost production coming on-stream through the second halfSave18 February 2020
NewsSpoils of war for Games Workshop?The three principals have sold £1.3m in sharesSave13 February 2020
NewsImperial impairs on vape flavour podsThe tobacco heavyweight has been hit by another setback for its vaping brandsSave5 February 2020
¹û¶³´«Ã½ of the WeekPorvair's gross margin pinchedThe industrial emissions specialist continues to drive the top lineSave4 February 2020
NewsGSK, Ashmore and Barratt Developments A selection of the latest updates from the ¹û¶³´«Ã½ Companies teamSave1 February 2020